I've tested a variety of tablets in various sizes and price classes to find the top tablets available right now ...
The tablet market experienced steady growth driven by increasing consumer demand for portable devices in 2024, which are ...
Net debt/EBITDA was 1.7 times in fiscal 2023, but we expect this ratio to increase temporarily above 3 times with the acquisition of 1E. Leverage should decline again in the next few years given the ...
The Indian tablet market saw a significant 25% year-on-year (YoY) growth in 2024, as per CyberMedia Research (CMR)’s Tablet ...
Apple led the overall tablet market in India with a 29% market share, followed closely by Samsung at 28% and Lenovo at 16%, ...
Apple Leads The Overall Tablet Market In India. Apple led the overall tablet market in India in 2024 with securing a 29 per ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...
Taiyo Yuden will benefit from increased passive components per phone as a result of advancing technology in telecommunications. In particular, diffusion of LTE and LTE-advanced networks and phones ...
Apple is again leading the tablet market with its iPad lineup. In the fourth quarter of 2024, Apple was able to secure 42.3 ...
We recently published a list of 10 Small–Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results